The invention relates to a method for fixing substrate molecules in gel matrices.

The present invention relates to a method for binding antibody or antigen molecules to solid phase.

The functional layer can bind molecules, which causes an electrical signal in the sensor.

Binding Drug Compounds to the Body’s Own LRP-1 Receptor

The Solution: Binding Drug Compounds to the Body’s Own LRP-1 Receptor

This invention provides a new procedure for attaching molecules to semiconductor surfaces, in particular silicon.

A multifunctional reagent useful for the attachment of desired molecules to appropriate support surfaces, in order to provide the surfaces with desired properties.

In the case of long-lasting bonds, the dendrimers can be used to bind anionic molecules to surfaces.

The gate region includes a multi-layered matrix of electrically conductive material with capture molecules for binding target molecules, such as antibody, receptors, DNA, RNA, peptides and aptamer.

The Solution: Binding Drug Compounds to the Body’s Own LRP-1 Receptor

Binding Drug Compounds to the Body’s Own LRP-1 Receptor

The graphene sheet may comprise affinity probes immobilized on the edges for attaching specific molecules to the graphene sheet.

For example, the modified materials can include free sulfhydryl group, which can serve as a linker to attach biologically active molecules.

It also has adsorption properties, or in other words, it can attract molecules that adhere to its surface.

In this method, the ultraviolet light reactive molecules are attached to the reinforcing agents like carbon nanotubes.